drugset / Trial / NCT00785460
Benfotiamine Prevents Vascular Dysfunction in Healthy Smokers
RandomizedCrossoverSingle-blindPrevention
Summary
Benfotiamine pretreatment (3 days)at high dosage (1050 mg/day) prevents in healthy subjects smoking-induced vascular dysfunction assessed by ultrasound flow mediated dilatation of the brachial artery.
Timeline
- Start
- 2008-01
- Primary completion
- 2008-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Benfotiamine | Small molecule | 1050 mg | — |
Indications
No indication recorded.